powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1487017950
Sarah Regan
Hematology-Oncology
Baltimore,
MD
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
Healthparse Signals
Monitor this provider for changes — dated NPI change events
PRESCRIBING · PART D · 2024
Total Rx claims
439
Beneficiaries
—
Total drug cost
$1.1M
Distinct drugs
16
Brand share
26.9%
Top prescribed drugs
Anastrozole
91 claims
Hydroxyurea
51 claims
Letrozole
40 claims
Exemestane
35 claims
Rivaroxaban
34 claims
QUALITY · MIPS · 2024
Final MIPS score
85.8
Quality
71.7
Cost
74.4
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.46%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$600
Payment records
24
By payment type
Food and Beverage
$600
Top paying entities
Food and Beverage
$600
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
2,451
Unique beneficiaries
—
Total services
60,472
Distinct HCPCS
59
Medicare payment
$995K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 175 Hematology-Oncology providers in MD — above median (cohort median 11,156).
